View More View Less
  • 1 University of Szeged Department of Surgery, Faculty of Medicine Szeged Hungary
  • | 2 University of Szeged First Department of Medicine, Faculty of Medicine Szeged Hungary
  • | 3 University of Szeged Department of Medical Informatics, Faculty of Medicine Szeged Hungary
  • | 4 University of Szeged Department of Medical Communication and Translation Szeged Hungary
  • | 5 University of Szeged Department of Surgery, Faculty of Medicine Pécsi u. 6 H-6720 Szeged Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

The incidence of post-transplant diabetes mellitus and its effects on the kidney allograft function and morphology were assessed. Patients were divided into three groups according to their glucose metabolism. Risk factors for diabetes were first assessed, and then changes in renal function were checked. Morphological changes in the allografts were examined by protocol biopsies. The overall incidence of diabetes was 16%. The development of diabetes was influenced significantly by the body mass index, the body weight and the age of the recipient. The incidence of diabetes was 8.6% in patients on cyclosporine A therapy and 28.8% in those on tacrolimus (p < 0.05). As to the morphology of the kidney, a significantly higher proportion of the biopsies showed severe interstitial fibrosis/tubular atrophy (p = 0.0004) and subclinical acute rejection ( p = 0.001) in the diabetic group compared to the normal one. This clinical study has revealed that the adverse effect of diabetes on the allograft can be detected with protocol biopsy before the manifestation of a functional deterioration.

  • American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 33,Suppl. 1 (2010)

  • Arif M, Arif MK, Arif MS: An evoluation of renal biopsy in type-II diabetic patients. J. Cole Physicians Surg. Pak. 19, 627–631 (2009)

    Arif M.S. , 'An evoluation of renal biopsy in type-II diabetic patients ' (2009 ) 19 J. Cole Physicians Surg. Pak. : 627 -631.

    • Search Google Scholar
  • Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K: DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 47, 2118–2128 (2004)

    Pyörälä K. , 'DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study ' (2004 ) 47 Diabetologia : 2118 -2128.

    • Search Google Scholar
  • Borda B, Szederkényi E, Lengyel C, Morvay Z, Eller J, Marofka F, Szabó V, Takács T, Szenohradszky P, Hódi Z, Lázár Gy: Functional and histopathological changes in renal transplant patients with new-onset diabetes and dyslipidemia. Transplant. Proc. 43, 1254–1258 (2011)

    Lázár G. , 'Functional and histopathological changes in renal transplant patients with new-onset diabetes and dyslipidemia ' (2011 ) 43 Transplant. Proc. : 1254 -1258.

    • Search Google Scholar
  • Ciancio G, Burke GW, Gaynor JJ, Ruiz P, Roth D, Kupin W, Rosen A, Miller J: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporin/sirolimus in renal transplantation: three-year analysis. Transplantation 81, 845–852 (2006)

    Miller J. , 'A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporin/sirolimus in renal transplantation: three-year analysis ' (2006 ) 81 Transplantation : 845 -852.

    • Search Google Scholar
  • Cosio FG, Kudva Y, Veldel M, Larson ST, Textor CS, Griffin DM, Stegall DM: New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 67, 2415–2421 (2005)

    Stegall D.M. , 'New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation ' (2005 ) 67 Kidney Int. : 2415 -2421.

    • Search Google Scholar
  • Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC: New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation. 75(Suppl. 10), SS3–SS24 (2003)

    Wheeler D.C. , 'New-onset diabetes after transplantation: 2003 international consensus guidelines ' (2003 ) 75 Transplantation : SS3 -SS24.

    • Search Google Scholar
  • Fresnedo GF, Plumed JS, Arias M, Caba DC, Oliva MO: Progression factors in chronic kidney disease. Nonimmunological mechanisms. Nefrologia 29(Suppl. 1), 16–24 (2009)

    Oliva M.O. , 'Progression factors in chronic kidney disease ' (2009 ) 29 Nonimmunological mechanisms. Nefrologia : 16 -24.

    • Search Google Scholar
  • Gallon LG, Winoto J, Leventhal RJ, Parker AM, Kaufman BDl: Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin. J. Am. Soc. Nephrol. 1, 907–908 (2006)

    Kaufman B. , 'Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function ' (2006 ) 1 Clin. J. Am. Soc. Nephrol. : 907 -908.

    • Search Google Scholar
  • Heisel O, Heisel R, Balshaw R, Keown P: New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am. J. Transplant. 4, 583–595 (2004)

    Keown P. , 'New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis ' (2004 ) 4 Am. J. Transplant. : 583 -595.

    • Search Google Scholar
  • Helanterä I, Ortiz F, Räisänen-Sokolowski A, Koskinen P: Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies. Transpl. Int. 4, 374–381 (2010)

    Koskinen P. , 'Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies ' (2010 ) 4 Transpl. Int. : 374 -381.

    • Search Google Scholar
  • Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrançois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY: Diabetes mellitus after kidney transplantation a French multicentre observational study. Nephrol. Dial. Transplant. 22, 1986–1993 (2007)

    Benhamou P.Y. , 'Diabetes mellitus after kidney transplantation a French multicentre observational study ' (2007 ) 22 Nephrol. Dial. Transplant. : 1986 -1993.

    • Search Google Scholar
  • Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. 3, 178–185 (2003)

    Matas A.J. , 'Diabetes mellitus after kidney transplantation in the United States ' (2003 ) 3 Am. J. Transplant. : 178 -185.

    • Search Google Scholar
  • Kasiske BL, Chakkera AH, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J. Am. Soc. Nephrol. 11, 1735–1743 (2000)

    Roel J. , 'Explained and unexplained ischemic heart disease risk after renal transplantation ' (2000 ) 11 J. Am. Soc. Nephrol. : 1735 -1743.

    • Search Google Scholar
  • Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W: Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up. Transplant. Int. (Sep. 9) (2009)

  • Li C, Yang CW: The pathogenesis and treatment of chronic allograft nephropathy. Nat. Rev. Nephrol. 5, 513–519 (2009)

    Yang C.W. , 'The pathogenesis and treatment of chronic allograft nephropathy ' (2009 ) 5 Nat. Rev. Nephrol. : 513 -519.

    • Search Google Scholar
  • Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 25, 583–592 (2002)

    Kudva Y.C. , 'Posttransplantation diabetes: A systematic review of the literature ' (2002 ) 25 Diabetes Care : 583 -592.

    • Search Google Scholar
  • Moreau K: Post-transplantation diabetes mellitus. Nephrol. Ther. (Suppl. 1) S71–S76 (2006)

  • Ossareh S, Naseem S, Faraji MA, Bahrami Asl M, Yousefnejad A: Frequency and risk factors for posttransplant diabetes mellitus in Irianian renal transplant patients. Transplant. Proc. 41, 2814–2816 (2009)

    Yousefnejad A. , 'Frequency and risk factors for posttransplant diabetes mellitus in Irianian renal transplant patients ' (2009 ) 41 Transplant. Proc. : 2814 -2816.

    • Search Google Scholar
  • Pascual J, Quereda C, Zamora J, Hernández D: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantion 78, 1548–1556 (2004)

    Hernández D. , 'Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials ' (2004 ) 78 Transplantion : 1548 -1556.

    • Search Google Scholar
  • Racusen LC, Halloran FP, Solez K: Banff 2003 meeting report: new diagnostic insights and standards. Am. J. Transplant. 4, 1562–1566 (2004)

    Solez K. , 'Banff 2003 meeting report: new diagnostic insights and standards ' (2004 ) 4 Am. J. Transplant. : 1562 -1566.

    • Search Google Scholar
  • Schiel R, Heinrich S, Steiner T, Ott U, Stein G: Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis. Clin. Exp. Nephrol. 9, 164–169 (2005)

    Stein G. , 'Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis ' (2005 ) 9 Clin. Exp. Nephrol. : 164 -169.

    • Search Google Scholar
  • Seifi S, Rahbar M, Lessan-Pezeshki M, Khatami MR, Abbasi MR, Mahdavi-Mazdeh M, Ahmadi F, Maziar S: Posttransplant diabetes mellitus incidence and risk factors. Transplant. Proc. 41, 2811–2813 (2009)

    Maziar S. , 'Posttransplant diabetes mellitus incidence and risk factors ' (2009 ) 41 Transplant. Proc. : 2811 -2813.

    • Search Google Scholar
  • Shah T et al.: Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 82, 1673–1676 (2006)

    Shah T. , 'Risk factors for development of new-onset diabetes mellitus after kidney transplantation ' (2006 ) 82 Transplantation : 1673 -1676.

    • Search Google Scholar
  • Sharma A, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, Bunnapradist S: Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression. Transplant. Proc. 40, 2414–2415 (2008)

    Bunnapradist S. , 'Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression ' (2008 ) 40 Transplant. Proc. : 2414 -2415.

    • Search Google Scholar
  • Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’). Am. J. Transplant. 7, 518 (2007)

    Weening J.J. , 'Banff’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’) ' (2007 ) 7 Am. J. Transplant. : 518 -.

    • Search Google Scholar
  • Türk T, Pietruck F, Dolff S, Kribben A, Janssen OE, Mann K, Philipp T, Heemann U, Witzke O: Repeglinide in the management of new-onset diabetes mellitus after renal transplantation. Am. J. Transplant. 6, 842–846 (2006)

    Witzke O. , 'Repeglinide in the management of new-onset diabetes mellitus after renal transplantation ' (2006 ) 6 Am. J. Transplant. : 842 -846.

    • Search Google Scholar
  • Valderhang TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J: Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88, 429–434 (2009)

    Hjelmesaeth J. , 'Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation ' (2009 ) 88 Transplantation : 429 -434.

    • Search Google Scholar
  • Van Duijnhoven EM, Boots JM, Christiaans MH, van Hooff JP: Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus. Minerva Urol. Nefrol. 55, 33–42 (2003)

    Hooff J.P. , 'Metabolic aspects of tacrolimus in renal transplantation ' (2003 ) 55 Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus. Minerva Urol. Nefrol. : 33 -42.

    • Search Google Scholar
  • Veroux M, Coronaa D, Giuffridaa G, Gaglianoa M, Sorbellob M, Virgilioa C, Tallaritaa T, Zerboa D, Giaquintaa A, Fiamingoa P, Macaronea M, Li Voltia G, Cagliaa B, Veroux P: New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression. Transplant. Proc. 40, 1885–1887 (2008)

    Veroux P. , 'New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression ' (2008 ) 40 Transplant. Proc. : 1885 -1887.

    • Search Google Scholar
  • Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 7, 1–9 (2007)

    Goto N. , 'Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus ' (2007 ) 7 Am. J. Transplant. : 1 -9.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 2 0 0
Jun 2021 0 0 0
Jul 2021 4 0 0
Aug 2021 14 0 0
Sep 2021 1 0 0
Oct 2021 1 0 0
Nov 2021 0 0 0